Use of posaconazole in the management of invasive orbital aspergillosis in a cat

Journal of the American Animal Hospital Association

Volumn 42, Issue 4, 2006, Pages 302-307

  McLellan, Gillian J ^a   Aquino, Susette M ^a   Mason, David R ^a   Kinyon, Joann M ^a   Myers, Ronald K ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIBIOTIC AGENT; BACITRACIN; CEFALEXIN; CHLORTETRACYCLINE; CORTICOSTEROID; ITRACONAZOLE; KETOPROFEN; NEOMYCIN; POLYMYXIN B; POSACONAZOLE; PREDNISONE;

ARTICLE; ASPERGILLOSIS; CAT DISEASE; CHRONIC DISEASE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG USE; ECHOGRAPHY; ERYTHEMA; EXOPHTHALMOS; EYE SURGERY; FOLLOW UP; FUNGUS ISOLATION; HISTOPATHOLOGY; MALE; MOUTH CAVITY; NONHUMAN; ORBIT DISEASE; POSTOPERATIVE PAIN; PRURITUS;

ASPERGILLUS FUMIGATUS;

EID: 33746160594     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0420302     Document Type: Article

References (44)

1. Gilger BC, McLaughlin SA, Whitley RD, et al. Orbital neoplasms in cats: 21 cases (1974-1990). J Am Vet Med Assoc 1992;201:1083-1086.
2. Calia CM, Kirschner SE, Baer KE, et al. The use of computed tomography scan for the evaluation of orbital disease in cats and dogs. Vet Compar Ophthalmol 1994;4:24-30.
3. Attali-Soussay K, Jegou JP, Clerc B. Retrobulbar tumors in dogs and cats: 25 cases. Vet Ophthalmol 2001;4:19-27.
4. McCalla TL, Moore CP. Exophthalmos in dogs and cats - part II. Compend Contin Educ Pract Vet 1989;11:911-926.
5. Ramsey DT, Marretta SM Hamor RE, et al. Ophthalmic manifestations and complications of dental disease in dogs and cats. J Am Anim Hosp Assoc 1996;32:215-224.
6. Latimer CA, Wyman M, Burt JK. What is your diagnosis? J Am Vet Med Assoc 1983;182:1401-1402.
7. Miller SA, van der Woerdt A, Bartick TE. Retrobulbar pseudotumor of the orbit in a cat. J Am Vet Med Assoc 2000;216:345,356-358.
8. Dziezyc J, Barton CL. Exophthalmia in a cat caused by an eosinophilic infiltrate. Prog Vet Compar Ophthalmol 1992;2:91-93.
9. Speakman AJ, Baines SJ, Williams JM, et al Zygomatic salivary cyst with mucocele formation in a cat. J Small Anim Pract 1997;38:468-470.
10. Davies C, Troy GC. Deep mycotic infections in cats. J Am Anim Hosp Assoc 1996;32:380-391.
11. Gerds-Grogan S, Dayrell-Hart B. Feline cryptococcosis: a retrospective evaluation. J Am Anim Hosp Assoc 1997;33:118-122.
12. Jacobs GJ, Medleau L, Calvert C, et al. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. J Vet Intern Med 1997;11:1-4.
13. Halenda RM, Reed AL. Ultrasound/computed tomography diagnosis - fungal sinusitis and retrobulbar myofascitis in a cat. Vet Radiol Ultrasound 1997;38:208-210.
14. Hamilton HL, Whitley RD, McLaughlin SA. Exophthalmos secondary to aspergillosis in a cat. J Am Anim Hosp Assoc 2000;36:343-347.
15. Peiffer RLJ, Belkin PV, Janke BH. Orbital cellulitis, sinusitis, and pneumonitis caused by Penicillium sp. in a cat. J Am Vet Med Assoc 1980;176:449-451.
16. Wilkinson GT, Sutton RH, Grono LR. Aspergillus spp. infection associated with orbital cellulitis and sinusitis in a cat. J Small Anim Pract 1982;23:127-131.
17. Ossent P. Systemic aspergillosis and mucormycosis in 23 cats. Vet Rec 1987;120:330-333.
18. Tomsa K, Glaus TM, Zimmer C, et al. Fungal rhinitis and sinusitis in three cats. J Am Vet Med Assoc 2003;222:1365,1380-1384.
19. Bissonnette KW, Sharp NJ, Dykstra MH, et al. Nasal and retrobulbar mass in a cat caused by Pythium insidiosum. J Med Vet Mycol 1991;29:39-44.
20. Gionfriddo JR. Feline systemic fungal infections. Vet Clin North Am Small Anim Pract 2000;30:1029-1050.
21. Gilger BC, Whitley RD, McLaughlin SA. Modified lateral orbitotomy for removal of orbital neoplasms in two dogs. Vet Surg 1994;23:53-58.
22. Levin LA, Avery R, Shore JW, et al. The spectrum of orbital aspergillosis: a clinicopathological review. Surv Ophthalmol 1996;41:142-154.
23. Latge J-P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-350.
24. Massry GG, Hornblass A, Harrison W. Itraconazole in the treatment of orbital aspergillosis. Ophthalmology 1996;103:1467-1470.
25. Samuelson DA, Andresen TL, Gwin RM. Conjunctival fungal flora in horses, cattle, dogs and cats. J Am Vet Med Assoc 1984;184:1240-1242.
26. Sierra P, Guillot J, Jacob H, et al. Fungal flora on cutaneous and mucosal surfaces of cats infected with feline immunodeficiency virus or feline leukemia virus. Am J Vet Res 2000;61:158-161.
27. Michaels L, Lloyd G, Phelps P. Origin and spread of allergic fungal disease of the nose and paranasal sinuses. Clin Otolaryngol 2000;25:518-525.
28. McCalla TL, Moore CP. Exophthalmos in dogs and cats. Part 1. Anatomic and diagnostic considerations. Compend Contin Educ Pract Vet 1989;11:784-792.
29. Boydell P. Fine needle aspiration biopsy in the diagnosis of exophthalmos. J Small Anim Pract 1991;32:542-546.
30. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp,: implications for pathogenesis. Microbiology 1994;140(Pt 9):2475-2479.
31. Medleau L, Jacobs GJ, Marks MA. Itraconazole for the treatment of cryptococcosis in cats. J Vet Intern Med 1995;9:39-42.
32. Boothe DM, Herring I, Calvin J, et al. Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats. Am J Vet Res 1997;58:872-877.
33. Moore CB, Sayers N, Mosquera J, et al. Antifungal drug resistance in Aspergillus. J Infect 2000;41:203-220.
34. Grooters AM, Taboada J. Update on antifungal therapy. Vet Clin North Am Small Anim Pract 2003;33:749-758.
35. Malik R, Craig AJ, Wigney DI, et al. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 1996;73:124-128.
36. Lewis RE, Prince RA, Chi J, et al. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2002;46:3208-3214.
37. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins mk-0991 (1-743,872) and ly303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998;36:2950-2956.
38. Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from sentry antimicrobial surveillance program, 2000. Antimicrob Agents Chemother 2002;46:1032-1037.
39. Oakley KL, Moore CB, Denning DW. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob Agents Chemother 1997;41:1124-1126.
40. Oakley KL, Morrissey G, Denning DW. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob Agents Chemother 1997;41:1504-1507.
41. Kirkpatrick WR, McAtee RK, Fothergill AW, et al. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother 2000;44:780-782.
42. Nomeir AA, Kumari P, Hilbert MJ, et al. Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother 2000;44:727-731.
43. Mosquera J, Denning DW.Azole cross-resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2002;46:556-557.
44. Manavathu EK, Cutright JL, Loebenberg D, et al. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592). J Antimicrob Chemother 2000;46:229-234.